Form 4: Procept BioRobotics CEO Exercises Stock Options
SEC Form 4 Filing
Reza Zadno, CEO of Procept BioRobotics, exercised stock options on July 31, 2024, acquiring 23,484 shares of common stock at $4.37 per share.
Summary
- On July 31, 2024, Reza Zadno, the President and CEO of Procept BioRobotics Corp, exercised stock options.
- This transaction involved the acquisition of 23,484 shares of common stock at a price of $4.37 per share.
- Following the transaction, Zadno directly owns 258,445 shares of common stock.
- Zadno also holds options to purchase 1,249,609 shares of common stock.
- The stock options were granted on February 20, 2020, and vested over a four-year period.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the increase in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/20/2020 | Date the stock options were granted. |
| 02/19/2030 | Expiration date of the stock options. |
| 07/31/2024 | Date of the transaction (exercise of stock options). |
| 08/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.